| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $26.6M | -61.8% |
| SG&A Expense | $68.8M | -4.2% |
| Operating Income | -$95.4M | +32.6% |
| Income Tax | $0 | — |
| Net Income | -$91.0M | -273.7% |
| EPS (Basic) | -$1.88 | -254.7% |
| EPS (Diluted) | -$1.88 | -28.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $95.5M | -25.7% |
| Current Assets | $97.7M | -28.4% |
| Total Assets | $118.4M | -24.9% |
| Current Liabilities | $43.8M | +273.1% |
| Total Liabilities | $44.0M | +271.6% |
| Stockholders' Equity | $74.4M | -48.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.3M | +72.4% |
| Capital Expenditures | $581K | +464.1% |
| Investing Cash Flow | -$581K | -464.1% |
| Financing Cash Flow | -$239K | -100.2% |
| Free Cash Flow | -$32.8M | +71.9% |